Table 2.
Univariate | Multivariate | ||||||
---|---|---|---|---|---|---|---|
HR | (95% CI) | P | HR | (95% CI) | P | ||
Histological grade | Absent | 1.0 | 1.0 | ||||
Present | 1.6 | (1.10–2.46) | 0.017 | 1.2 | (0.76–1.84) | ns | |
BVI | Absent | 1.0 | 1.0 | ||||
Present | 2.2 | (1.42–3.27) | <0.001 | 1.3 | (0.84–2.05) | ns | |
LVI | Absent | 1.0 | 1.0 | ||||
Present | 2.7 | (1.79–4.15) | <0.001 | 1.8 | (1.10–2.77) | 0.017 | |
Tumour necrosis | Absent | 1.0 | 1.0 | ||||
Present | 2.2 | (1.39–3.32) | 0.001 | 1.5 | (0.92–2.40) | ns | |
VPIa | Low | 1.0 | 1.0 | ||||
High | 1.7 | (1.08–2.60) | 0.022 | 1.7 | (1.04–2.68) | 0.033 | |
Tumour stage | I | 1.0 | 1.0 | ||||
II–IV | 4.3 | (2.63–7.18) | <0.001 | 3.1 | (1.78–5.38) | <0.001 |
HR, hazard ratio; CI, confidence interval; VPI, vascular proliferation index; BVI, blood vessel invasion; LVI, lymph vessel invasion; ns, non‐significant (P value > 0.05).
By upper quartile, 4.4%.